Synthes outshines Stryker in prosperous Q2
This article was originally published in Clinica
Executive Summary
Swiss orthopaedics firm Synthes has surpassed analysts’ expectations by posting growth on both its top- and bottom-lines during the second quarter of 2009. The firm’s rival in the orthopaedics space, Stryker, was unable to match this performance, reporting lower sales and decreased net income compared to the same period the previous year.